CIK 0001601485 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Elicio Therapeutics, Inc.
Sign in to watch- Ticker
- ELTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113430072
- Phone
- (857) 209-0050
- Business address
- 451 D STREET, 5TH FLOOR, BOSTON, MA, 02210
- Former names
- Angion Biomedica Corp.
- 8-K Event Delisting notice
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Exit or restructuring costs · Executive or director change
- 4 Shares withheld for taxes Director gave up 32,082 shares (to pay taxes)
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Open-market sale See Remarks sold 159,177 shares at $16.00 ($2,546,832)
- 4/A Open-market sale Director sold 246,720 shares at $16.00 ($3,947,520)
- 4 Open-market buy See Remarks bought 11,313 shares at $1.25 ($14,103)
- 4 Open-market buy See Remarks bought 82,200 shares at an average $1.23 ($101,428)
- 424B5 Offering Prospectus
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 4 Open-market buy Director bought 9,383 shares at an average $1.16 ($10,925)
Page 13 of 20 · 384 filings